Home Data Calendar Blog

ITOS

Tables

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Common Stock Value 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04

dei: Entity Common Stock Shares Outstanding NA NA NA NA NA NA NA NA NA NA

Earnings Per Share Basic -0.85 -0.90 -0.96 -0.44 0.58 0.03 0.16 1.96 5.26 1.98

Earnings Per Share Diluted -0.85 -0.90 -0.96 -0.44 0.55 0.03 0.15 1.82 4.89 1.86

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Revenue From Contract With Customer Including Assessed Tax 0.00 0.00 0.00 12.60 53.91 19.49 41.72 152.52 240.50 104.27

Revenues 0.00 0.00 0.00 12.60 53.91 19.49 41.72 152.52 240.50 104.27

Operating Expenses 40.15 43.28 42.62 37.52 36.52 34.69 38.38 31.71 26.98 24.86

Research And Development Expense 27.78 30.64 29.19 25.60 25.42 23.93 26.91 21.10 17.39 16.10

General And Administrative Expense 12.37 12.64 13.44 11.93 11.10 10.76 11.47 10.62 9.60 8.76

Operating Income Loss -40.15 -43.28 -42.62 -24.93 17.38 -15.21 3.33 120.81 213.52 79.41

Allocated Share Based Compensation Expense 7.19 7.06 6.96 5.81 5.88 5.72 5.76 4.19 4.04 3.94

Income Loss From Continuing Operations -30.55 -32.24 -34.30 -15.55 20.45 0.99 5.63 69.58 184.87 69.64

Income Loss From Continuing Operations Before Income Taxes Domestic -13.60 -20.39 -14.87 -21.32 -14.35 -18.62 -22.06 -14.89 -11.57 -5.47

Income Loss From Continuing Operations Before Income Taxes Foreign -14.59 -13.03 -18.20 6.96 37.10 16.64 30.51 134.42 235.62 77.88

Income Tax Expense Benefit 2.36 -1.18 1.23 1.20 2.29 -2.98 2.82 49.95 39.17 2.77

Income Taxes Paid Net 1.32 1.17 NA NA 9.05 7.03 NA NA NA NA

Profit Loss -30.55 -32.24 -34.30 -15.55 20.45 0.99 5.63 69.58 184.87 69.64

Net Income Loss -30.55 -32.24 -34.30 -15.55 20.45 0.99 5.63 69.58 184.87 69.64

Comprehensive Income Net Of Tax -30.53 -32.33 -35.92 -17.45 22.93 -8.82 4.88 69.03 175.10 78.16

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Assets 667.59 677.64 703.75 728.35 754.99 777.87 814.77 850.32 884.71 922.38

Liabilities 92.36 79.38 80.22 76.08 91.66 143.67 177.47 223.94 331.89 550.34

Liabilities And Stockholders Equity 667.59 677.64 703.75 728.35 754.99 777.87 814.77 850.32 884.71 922.38

Stockholders Equity 575.23 598.26 623.53 652.26 663.33 634.20 637.30 626.38 552.82 372.04

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Assets Current 550.65 619.13 614.55 615.40 628.30 768.55 804.74 840.66 874.71 914.14

Cash And Cash Equivalents At Carrying Value 251.18 204.13 216.21 225.36 284.80 752.24 791.86 823.98 848.54 899.77

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 251.45 204.40 216.48 225.60 285.04 752.47 792.15 824.28 848.84 899.90

Short Term Investments 280.74 394.89 383.01 376.78 328.36 NA NA NA NA NA

Prepaid Expense And Other Assets Current 12.24 13.79 11.64 12.60 12.70 11.74 8.88 12.06 14.09 8.94

Available For Sale Securities Debt Securities 381.28 440.79 461.27 481.26 446.58 NA NA NA NA NA

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Property Plant And Equipment Gross 9.08 7.34 6.48 5.85 5.58 5.12 5.29 5.29 5.04 5.03

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 4.38 4.01 3.93 3.73 3.46 3.02 3.02 3.07 2.97 2.90

Property Plant And Equipment Net 4.70 3.33 2.55 2.12 2.12 2.10 2.27 2.22 2.07 2.12

Long Term Investments 100.54 45.90 78.26 104.48 118.22 NA NA NA NA NA

Other Assets Noncurrent 0.88 0.88 0.81 0.33 0.33 0.31 0.32 0.32 0.30 0.27

Available For Sale Debt Securities Amortized Cost Basis 381.24 442.02 462.89 481.16 446.74 NA NA NA NA NA

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Liabilities Current 40.01 28.22 30.02 26.36 42.00 93.83 125.39 174.25 304.12 542.23

Accounts Payable Current 11.29 3.42 5.23 5.69 7.66 9.60 10.92 10.60 5.14 4.71

Accrued Liabilities Current 7.06 22.05 21.25 17.73 19.73 11.38 13.81 14.05 17.16 12.19

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Operating Lease Liability Noncurrent 4.81 4.81 4.43 3.76 3.84 3.73 4.03 4.46 4.57 2.38

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Stockholders Equity 575.23 598.26 623.53 652.26 663.33 634.20 637.30 626.38 552.82 372.04

Common Stock Value 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04

Additional Paid In Capital 463.80 456.30 449.23 442.05 435.67 429.47 423.74 417.70 413.18 407.50

Retained Earnings Accumulated Deficit 124.63 155.18 187.42 221.72 237.28 216.82 215.83 210.21 140.62 -44.25

Accumulated Other Comprehensive Income Loss Net Of Tax -13.24 -13.26 -13.17 -11.55 -9.64 -12.12 -2.31 -1.57 -1.02 8.75

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Net Cash Provided By Used In Operating Activities -13.77 -33.89 -29.55 -26.55 -27.17 -29.70 -30.32 -24.00 -58.82 605.00

Net Cash Provided By Used In Investing Activities 61.56 22.69 20.10 -31.69 -445.12 -0.10 -0.51 -0.32 -0.16 -0.53

Net Cash Provided By Used In Financing Activities 0.31 0.01 0.22 0.58 1.37 -0.00 0.28 0.33 2.36 0.44

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Net Cash Provided By Used In Operating Activities -13.77 -33.89 -29.55 -26.55 -27.17 -29.70 -30.32 -24.00 -58.82 605.00

Net Income Loss -30.55 -32.24 -34.30 -15.55 20.45 0.99 5.63 69.58 184.87 69.64

Profit Loss -30.55 -32.24 -34.30 -15.55 20.45 0.99 5.63 69.58 184.87 69.64

Increase Decrease In Accounts Payable 7.62 -2.07 -0.41 -2.10 -2.64 -1.04 0.98 5.46 0.52 -6.50

Share Based Compensation 7.19 7.06 6.96 5.81 5.88 5.72 5.76 4.19 4.04 3.94

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Net Cash Provided By Used In Investing Activities 61.56 22.69 20.10 -31.69 -445.12 -0.10 -0.51 -0.32 -0.16 -0.53

Payments To Acquire Property Plant And Equipment 1.40 0.75 0.70 0.12 0.12 0.08 0.51 0.23 0.16 0.53

Payments To Acquire Investments 97.03 54.47 86.46 52.58 NA NA NA NA NA NA

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Net Cash Provided By Used In Financing Activities 0.31 0.01 0.22 0.58 1.37 -0.00 0.28 0.33 2.36 0.44

2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30

Revenues 0.00 0.00 0.00 12.60 53.91 19.49 41.72 152.52 240.50 104.27

Revenue From Contract With Customer Including Assessed Tax 0.00 0.00 0.00 12.60 53.91 19.49 41.72 152.52 240.50 104.27

Adimab L L C, License And Service 0.00 0.00 0.00 5.40 0.00 2.00 0.00 3.40 0.00 0.00

Glaxo Smith Kline, License And Service 0.00 0.00 0.00 12.60 53.90 19.50 41.70 152.50 NA NA

Plots across concepts

IncomeStatement

Operating Income Loss

Expenses

Other Nonoperating Income Expense

Balance Sheet

Operating Lease Right Of Use Asset

Assets

Property Plant And Equipment Net

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Other Assets Noncurrent

PropertyPlantAndEquipmentNet

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

Liabilities

Operating Lease Liability

Current Liabilities

Operating Lease Liability Current

Stockholders Equity

Accumulated Other Comprehensive Income Loss Net Of Tax

CashFlow

Net Income Loss

NetCashProvidedByUsedInOperatingActivities

Net Income Loss

NetCashProvidedByUsedInInvestingActivities

Payments To Acquire Property Plant And Equipment

OperatingLeaseLiability

Operating Lease Liability Current

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Undiscounted Excess Amount

Line plots across dimensions of each concept